News

Protagonist Therapeutics, a clinical-stage biopharmaceutical company founded on IMB research, has won Australian Company of the Year at the AusBiotech Industry Excellence Awards.

IMB research has contributed to UQ's top ranking in the Nature Index 2016 Australia and New Zealand.

The future of medicine could be as simple as nibbling a sunflower seed or drinking a cup of tea, with the opening of a new IMB facility, officially opened the Hon Annastacia Palaszczuk, Queensland Premier and Minister for the Arts.

In a world-first, researchers from UQ IMB and University of Washington (UW) have produced tailor-made peptides – an advance expected to help improve drug design and environmentally-friendly pesticides. The team has designed ultra-stable peptide scaffolds that can be used in a range of biotechnological applications.

Does genetic susceptibility predispose women to postpartum depression? Researchers from UQ are calling on Australian mothers to help them find out.

Congratulations to IMB’s Dr Markus Muttenthaler who received the Miklós Bodanszky Award for his outstanding contributions to peptide science. 

Thanks to a $1.3 million state government research grant, IMB’s Dr Nathan Palpant has partnered with Professor John Fraser at The Prince Charles Hospital to develop next generation medical treatments to tackle heart disease, which claims the life of one Australian every 12 minutes.

Paralympian Chris Bond was 19 when a severe bacterial infection in his bowel spread through his body and sent him into septic shock. Today, on World Sepsis Day (13 September), Chris is working with IMB's Community for Open Antimicrobial Drug Discovery (CO-ADD) to bring attention to the multidrug-resistant bacteria that nearly took his life.

Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).

IMB’s Mathilde Desselle has won the Queensland Women in Technology (WiT) InfoTech Professional Award for her leadership of biomedical research programs and facilities in the fields of genomics, bioinformatics and drug discovery.

IMB research could lead to a new treatment for Parkinson’s disease, with future potential applications to nearly 50 other disorders.

Researchers from IMB and Imperial College London have developed a method to distinguish viral and bacterial infections in children, which will save lives and reduce antibiotic use.

IMB researcher Professor Kirill Alexandrov has received funding from the Bill & Melinda Gates Foundation to develop a cheap, portable biosensor to detect a range of infectious diseases, including Dengue fever and Zika virus.

IMB spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.

The National Health and Medical Research Council has named two UQ projects among its 10 of the Best Research Projects 2015, including IMB Group Leader Professor David Craik's project named “The scorpion king: lighting the way to defeating brain cancer”. These projects have led to ground-breaking medical discoveries and important changes to healthcare.

Applications are now open for the IMB Research Advancement Award, offering brilliant prospective PhD students the opportunity to secure a $30,000 top-up scholarship to support their studies at IMB.

IMB has welcomed three new research groups to bolster its investigations into neurological and psychiatric disorders, including motor neuron disease, Parkinson’s disease, dementia, autism and schizophrenia.

It is possible to combine family and a love of science. PhD graduate Rubbiya Ali looks back on everything she’s achieved at UQ, including mapping microalgae to help produce more efficient biofuels and having a son.

UQ Bachelor of Biomedical Science (honours) graduating student Samantha Nixon has been investigating compounds from tarantula venom as a potential treatment for sheep parasites which lead to huge economic losses for farmers.

Catch up on the free community seminar, Pain: Making it personal, hosted by the IMB Centre for Pain Research.